Annual CFI
-$11.50 K
+$390.50 K+97.14%
31 December 2023
Summary:
China Pharma Holdings annual cash flow from investing activities is currently -$11.50 thousand, with the most recent change of +$390.50 thousand (+97.14%) on 31 December 2023. During the last 3 years, it has risen by +$855.80 thousand (+98.67%). CPHI annual CFI is now -135.28% below its all-time high of $32.60 thousand, reached on 30 June 2003.CPHI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$9200.00
+$37.30 K+132.74%
30 September 2024
Summary:
China Pharma Holdings quarterly cash flow from investing activities is currently $9200.00, with the most recent change of +$37.30 thousand (+132.74%) on 30 September 2024. Over the past year, it has increased by +$76.70 thousand (+113.63%). CPHI quarterly CFI is now -98.44% below its all-time high of $591.10 thousand, reached on 31 December 2007.CPHI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$23.40 K
+$76.70 K+76.62%
30 September 2024
Summary:
China Pharma Holdings TTM cash flow from investing activities is currently -$23.40 thousand, with the most recent change of +$76.70 thousand (+76.62%) on 30 September 2024. Over the past year, it has dropped by -$43.70 thousand (-215.27%). CPHI TTM CFI is now -118.17% below its all-time high of $128.80 thousand, reached on 30 September 2005.CPHI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +97.1% | +113.6% | -215.3% |
3 y3 years | +98.7% | +102.2% | +88.2% |
5 y5 years | +77.5% | +175.4% | +77.4% |
CPHI Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +98.7% | -83.6% | +102.2% | -215.3% | +96.1% |
5 y | 5 years | at high | +98.7% | -96.0% | +101.9% | -215.3% | +98.0% |
alltime | all time | -135.3% | +99.9% | -98.4% | +100.1% | -118.2% | +99.9% |
China Pharma Holdings Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $9200.00(-132.7%) | -$23.40 K(-76.6%) |
June 2024 | - | -$28.10 K(<-9900.0%) | -$100.10 K(+48.3%) |
Mar 2024 | - | $0.00(-100.0%) | -$67.50 K(+487.0%) |
Dec 2023 | -$11.50 K(-97.1%) | -$4500.00(-93.3%) | -$11.50 K(-156.7%) |
Sept 2023 | - | -$67.50 K(-1600.0%) | $20.30 K(-112.3%) |
June 2023 | - | $4500.00(-92.0%) | -$164.70 K(-52.2%) |
Mar 2023 | - | $56.00 K(+105.1%) | -$344.50 K(-14.3%) |
Dec 2022 | -$402.00 K(-8.2%) | $27.30 K(-110.8%) | -$401.90 K(-7.9%) |
Sept 2022 | - | -$252.50 K(+44.0%) | -$436.30 K(-27.3%) |
June 2022 | - | -$175.30 K(>+9900.0%) | -$599.80 K(+36.5%) |
Mar 2022 | - | -$1400.00(-80.3%) | -$439.50 K(+0.3%) |
Dec 2021 | -$438.10 K(-49.5%) | -$7100.00(-98.3%) | -$438.10 K(+120.8%) |
Sept 2021 | - | -$416.00 K(+2673.3%) | -$198.40 K(+374.6%) |
June 2021 | - | -$15.00 K(<-9900.0%) | -$41.80 K(-92.0%) |
Mar 2021 | - | $0.00(-100.0%) | -$519.50 K(-40.1%) |
Dec 2020 | -$867.30 K(+537.7%) | $232.60 K(-189.7%) | -$867.30 K(-24.6%) |
Sept 2020 | - | -$259.40 K(-47.4%) | -$1.15 M(+27.4%) |
June 2020 | - | -$492.70 K(+41.7%) | -$903.00 K(+120.2%) |
Mar 2020 | - | -$347.80 K(+591.5%) | -$410.00 K(+201.2%) |
Dec 2019 | -$136.00 K(+166.1%) | -$50.30 K(+312.3%) | -$136.10 K(+31.4%) |
Sept 2019 | - | -$12.20 K(-4166.7%) | -$103.60 K(+9.3%) |
June 2019 | - | $300.00(-100.4%) | -$94.80 K(-22.0%) |
Mar 2019 | - | -$73.90 K(+315.2%) | -$121.50 K(+137.3%) |
Dec 2018 | -$51.10 K(-62.6%) | -$17.80 K(+423.5%) | -$51.20 K(-50.1%) |
Sept 2018 | - | -$3400.00(-87.1%) | -$102.60 K(-10.5%) |
June 2018 | - | -$26.40 K(+633.3%) | -$114.70 K(+1.1%) |
Mar 2018 | - | -$3600.00(-94.8%) | -$113.50 K(-16.8%) |
Dec 2017 | -$136.50 K(-29.4%) | -$69.20 K(+346.5%) | -$136.50 K(-21.7%) |
Sept 2017 | - | -$15.50 K(-38.5%) | -$174.40 K(-2.6%) |
June 2017 | - | -$25.20 K(-5.3%) | -$179.00 K(-1.0%) |
Mar 2017 | - | -$26.60 K(-75.2%) | -$180.80 K(-6.5%) |
Dec 2016 | -$193.40 K(-89.8%) | -$107.10 K(+432.8%) | -$193.40 K(-90.2%) |
Sept 2016 | - | -$20.10 K(-25.6%) | -$1.98 M(+16.6%) |
June 2016 | - | -$27.00 K(-31.1%) | -$1.70 M(-10.1%) |
Mar 2016 | - | -$39.20 K(-97.9%) | -$1.89 M(-0.4%) |
Dec 2015 | -$1.90 M(-74.5%) | -$1.89 M(-823.7%) | -$1.90 M(-25.5%) |
Sept 2015 | - | $261.50 K(-220.1%) | -$2.55 M(-19.1%) |
June 2015 | - | -$217.80 K(+362.4%) | -$3.15 M(-15.4%) |
Mar 2015 | - | -$47.10 K(-98.1%) | -$3.72 M(-49.9%) |
Dec 2014 | -$7.42 M(-61.1%) | -$2.54 M(+650.2%) | -$7.42 M(-47.8%) |
Sept 2014 | - | -$338.80 K(-57.1%) | -$14.21 M(-25.3%) |
June 2014 | - | -$789.80 K(-79.0%) | -$19.01 M(-15.3%) |
Mar 2014 | - | -$3.75 M(-59.8%) | -$22.44 M(+17.5%) |
Dec 2013 | -$19.09 M(+282.8%) | -$9.33 M(+81.4%) | -$19.09 M(+54.3%) |
Sept 2013 | - | -$5.14 M(+21.9%) | -$12.38 M(+49.6%) |
June 2013 | - | -$4.22 M(+942.9%) | -$8.27 M(+91.8%) |
Mar 2013 | - | -$404.40 K(-84.5%) | -$4.31 M(-13.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2012 | -$4.99 M(-11.3%) | -$2.61 M(+152.0%) | -$4.99 M(+53.2%) |
Sept 2012 | - | -$1.04 M(+301.3%) | -$3.26 M(-20.0%) |
June 2012 | - | -$258.40 K(-76.1%) | -$4.07 M(-23.6%) |
Mar 2012 | - | -$1.08 M(+22.6%) | -$5.33 M(-5.3%) |
Dec 2011 | -$5.63 M(-46.5%) | -$880.60 K(-52.5%) | -$5.63 M(-30.7%) |
Sept 2011 | - | -$1.85 M(+22.2%) | -$8.12 M(-3.7%) |
June 2011 | - | -$1.52 M(+10.0%) | -$8.43 M(-9.7%) |
Mar 2011 | - | -$1.38 M(-59.1%) | -$9.34 M(-11.2%) |
Dec 2010 | -$10.52 M(-31.5%) | -$3.37 M(+55.5%) | -$10.52 M(-10.2%) |
Sept 2010 | - | -$2.17 M(-10.5%) | -$11.71 M(-16.3%) |
June 2010 | - | -$2.42 M(-5.2%) | -$13.99 M(-6.9%) |
Mar 2010 | - | -$2.56 M(-43.9%) | -$15.02 M(-2.2%) |
Dec 2009 | -$15.36 M(+47.1%) | -$4.56 M(+2.7%) | -$15.36 M(+3.6%) |
Sept 2009 | - | -$4.44 M(+28.6%) | -$14.83 M(+5.3%) |
June 2009 | - | -$3.46 M(+19.2%) | -$14.09 M(+28.1%) |
Mar 2009 | - | -$2.90 M(-28.0%) | -$11.00 M(+5.3%) |
Dec 2008 | -$10.44 M(+605.7%) | -$4.03 M(+8.9%) | -$10.44 M(+79.4%) |
Sept 2008 | - | -$3.70 M(+910.3%) | -$5.82 M(+39.8%) |
June 2008 | - | -$366.30 K(-84.4%) | -$4.16 M(+7.9%) |
Mar 2008 | - | -$2.34 M(-496.5%) | -$3.86 M(+160.9%) |
Dec 2007 | -$1.48 M(+670.6%) | $591.10 K(-128.9%) | -$1.48 M(-29.3%) |
Sept 2007 | - | -$2.04 M(+3197.9%) | -$2.09 M(+2864.7%) |
June 2007 | - | -$62.00 K(-271.7%) | -$70.60 K(-46.2%) |
Mar 2007 | - | $36.10 K(-260.4%) | -$131.30 K(-31.6%) |
Dec 2006 | -$192.00 K(-43.8%) | -$22.50 K(+1.4%) | -$191.90 K(+13.3%) |
Sept 2006 | - | -$22.20 K(-81.9%) | -$169.40 K(+820.7%) |
June 2006 | - | -$122.70 K(+400.8%) | -$18.40 K(-117.6%) |
Mar 2006 | - | -$24.50 K(-119.0%) | $104.30 K(-19.0%) |
Dec 2005 | -$341.50 K(<-9900.0%) | - | - |
Sept 2005 | - | $128.80 K(>+9900.0%) | $128.80 K(>+9900.0%) |
June 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
June 2005 | $0.00(-100.0%) | - | - |
Mar 2005 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2004 | - | $0.00(0.0%) | $5000.00(>+9900.0%) |
Sept 2004 | - | $0.00(0.0%) | $0.00(-100.0%) |
June 2004 | $2500.00(-92.3%) | $0.00(-100.0%) | $2500.00(0.0%) |
Mar 2004 | - | $5000.00(-200.0%) | $2500.00(-75.5%) |
Dec 2003 | - | -$5000.00(-300.0%) | $10.20 K(-33.3%) |
Sept 2003 | - | $2500.00(>+9900.0%) | $15.30 K(-52.9%) |
June 2003 | $32.60 K(-113.0%) | $0.00(-100.0%) | $32.50 K(-23.5%) |
Mar 2003 | - | $12.70 K(>+9900.0%) | $42.50 K(-119.3%) |
Dec 2002 | - | $100.00(-99.5%) | -$220.20 K(-0.0%) |
Sept 2002 | - | $19.70 K(+97.0%) | -$220.30 K(-11.9%) |
June 2002 | -$250.00 K | $10.00 K(-104.0%) | -$250.00 K(-3.8%) |
Mar 2002 | - | -$250.00 K(<-9900.0%) | -$260.00 K(+2500.0%) |
Dec 2001 | - | $0.00(-100.0%) | -$10.00 K(0.0%) |
Sept 2001 | - | -$10.00 K | -$10.00 K |
FAQ
- What is China Pharma Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for China Pharma Holdings?
- What is China Pharma Holdings annual CFI year-on-year change?
- What is China Pharma Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for China Pharma Holdings?
- What is China Pharma Holdings quarterly CFI year-on-year change?
- What is China Pharma Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for China Pharma Holdings?
- What is China Pharma Holdings TTM CFI year-on-year change?
What is China Pharma Holdings annual cash flow from investing activities?
The current annual CFI of CPHI is -$11.50 K
What is the all time high annual CFI for China Pharma Holdings?
China Pharma Holdings all-time high annual cash flow from investing activities is $32.60 K
What is China Pharma Holdings annual CFI year-on-year change?
Over the past year, CPHI annual cash flow from investing activities has changed by +$390.50 K (+97.14%)
What is China Pharma Holdings quarterly cash flow from investing activities?
The current quarterly CFI of CPHI is $9200.00
What is the all time high quarterly CFI for China Pharma Holdings?
China Pharma Holdings all-time high quarterly cash flow from investing activities is $591.10 K
What is China Pharma Holdings quarterly CFI year-on-year change?
Over the past year, CPHI quarterly cash flow from investing activities has changed by +$76.70 K (+113.63%)
What is China Pharma Holdings TTM cash flow from investing activities?
The current TTM CFI of CPHI is -$23.40 K
What is the all time high TTM CFI for China Pharma Holdings?
China Pharma Holdings all-time high TTM cash flow from investing activities is $128.80 K
What is China Pharma Holdings TTM CFI year-on-year change?
Over the past year, CPHI TTM cash flow from investing activities has changed by -$43.70 K (-215.27%)